Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells.

作者: Ting Li , Wen-Shan Xu , Guo-Sheng Wu , Xiu-Ping Chen , Yi-Tao Wang

DOI: 10.7314/APJCP.2014.15.4.1745

关键词:

摘要: BACKGROUND Platycodin D (PD), a triterpenoid saponin isolated from the Chinese medicinal herb Platycodonis radix, possesses anti-cancer effects in several cancer cell lines. The aim of this study was to evaluate its anti- activities hepatocellular carcinoma cells. MATERIALS AND METHODS MTT and colony formation assays were performed proliferation, along with flow cytometry Western blotting for apoptosis. Cell adhesion tested by observing cellular morphology under microscope, while transwell assay employed investigate migration invasion. RESULTS PD concentration-dependently inhibited proliferation both HepG2 Hep3B cells, significantly suppressed induced apoptosis protein levels cleaved poly ADP-ribose polymerase (PARP) Bax up-regulated that survivin down-regulated after treatment PD. Moreover, not only obviously cells Matrigel, but also remarkably depressed their invasion 12-O-tetradecanoylphorbol 13-acetate (TPA). CONCLUSIONS presents potential via inducing apoptosis, inhibiting adhesion, invasion, indicating promising features as lead compound agent development.

参考文章(27)
Ji Sun Yu, An Keun Kim, Platycodin D Induces Apoptosis in MCF-7 Human Breast Cancer Cells Journal of Medicinal Food. ,vol. 13, pp. 298- 305 ,(2010) , 10.1089/JMF.2009.1226
Hugh J.M Brady, Gabriel Gil-Gómez, Molecules in focus Bax. The pro-apoptotic Bcl-2 family member, Bax The International Journal of Biochemistry & Cell Biology. ,vol. 30, pp. 647- 650 ,(1998) , 10.1016/S1357-2725(98)00006-5
Chris S Hughes, Lynne M Postovit, Gilles A Lajoie, None, Matrigel: A complex protein mixture required for optimal growth of cell culture Proteomics. ,vol. 10, pp. 1886- 1890 ,(2010) , 10.1002/PMIC.200900758
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
Dong Yeok Shin, Gi Young Kim, Wei Li, Byung Tae Choi, Nam Deuk Kim, Ho Sung Kang, Yung Hyun Choi, Implication of intracellular ROS formation, caspase-3 activation and Egr-1 induction in platycodon D-induced apoptosis of U937 human leukemia cells Biomedicine & Pharmacotherapy. ,vol. 63, pp. 86- 94 ,(2009) , 10.1016/J.BIOPHA.2008.08.001
Seong-Soo Choi, Eun-Jung Han, Tae-Hee Lee, Jin-Koo Lee, Ki-Jung Han, Han-Kyu Lee, Hong-Won Suh, Antinociceptive Mechanisms of Platycodin D Administered Intracerebroventricularly in the Mouse Planta Medica. ,vol. 68, pp. 794- 798 ,(2002) , 10.1055/S-2002-34396
Kwang Seok Ahn, Eun Jung Noh, Hai Lin Zhao, Sang Hoon Jung, Sam Sik Kang, Yeong Shik Kim, Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells Life Sciences. ,vol. 76, pp. 2315- 2328 ,(2005) , 10.1016/J.LFS.2004.10.042
Mun-Ock Kim, Dong-Oh Moon, Yung Hyun Choi, Jae-Dong Lee, Nam Deuk Kim, Gi-Young Kim, Platycodin D induces mitotic arrest in vitro, leading to endoreduplication, inhibition of proliferation and apoptosis in leukemia cells. International Journal of Cancer. ,vol. 122, pp. 2674- 2681 ,(2008) , 10.1002/IJC.23442
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, Karin Burock, Jessie Zou, Dimitris Voliotis, Zhongzhen Guan, None, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncology. ,vol. 10, pp. 25- 34 ,(2009) , 10.1016/S1470-2045(08)70285-7